What Abu Dhabi's Longevity Outcome Indicators Mean for Hospital Groups

Dr. Ana Baroni
Dr. Ana Baroni
Medical Strategy & Clinical Leadership

MD, PhD in Molecular Diagnostics (Cum Laude), with over 27 years of clinical practice in precision, regenerative, functional, and integrative medicine. She is Chief Scientific Officer at Longevity.Tech.fund and Chief Medical Officer at HealthyLongevity.clinic.

Abu Dhabi has done something much of the longevity market has avoided. It has written down what success in longevity medicine outcomes looks like.

What the JAWDA Guidance Requires

The Department of Health issued its Healthy Longevity Medicine JAWDA guidance in May. It applies from the second half of 2026. It asks longevity providers in the emirate to report outcomes twice a year.

The question is no longer how many tests a provider sold. It is how many patients changed.

The Indicators Read Like a Capacity Assessment

VO2max must improve by at least 5% at twelve months, or stay in the optimal range. Providers must also close at least 20% of the gap to an individual target for HbA1c, blood pressure, and LDL.

In addition, body composition by DEXA at six months counts muscle alongside fat. Cognition joins the list from the first half of 2027. Furthermore, the guidance sets targets per patient rather than one uniform threshold.

What the Clinic Standard Leaves Out

The emirate’s clinic standard lists DNA methylation and whole body MRI as optional and in need of further validation. It does not recommend telomere length outside research. Consequently, the test menu matters less than the measured change.

Why Retention Becomes the Real Offer

For hospital groups and resort operators designing longevity solutions, the lesson is operational. The VO2max indicator only counts patients seen at least four times in twelve months.

Therefore, retention, follow-up, and a named physician who owns each abnormal result become the real offer. A one-visit package cannot meet the indicator.

What Hospital Groups Should Do Now

First, map every program against the indicators and note which results the team can already measure. Next, schedule at least four patient contacts across twelve months. Then, assign a named physician to each abnormal result.

Additionally, set targets per patient at intake. A uniform threshold does not match the guidance, and it hides the patients who need the most support.

A Twelve-Month Calendar for a Provider

A provider can turn the indicators into a simple calendar. Record a baseline at intake. Book follow-up visits across the year so that each patient reaches at least four contacts. Schedule body composition by DEXA at six months. Then review VO2max and the other measures at twelve months.

Consequently, the reporting cycle becomes routine. In addition, the team sees early which patients are slipping away, so physicians can contact them before the year ends.

What Resort Operators Should Understand

A resort that adds a longevity offer faces the same standard if it operates in the emirate. A guest who visits once cannot generate the follow-up data. Therefore, resorts need a plan for contact after checkout, and a named physician who owns each abnormal result.

Expect Other Regulators to Follow

Providers outside Abu Dhabi can still use the indicators as a model. Clear outcome measures are easy to copy, and they suit any longevity program. Therefore, providers that build outcome tracking now will be ready if another jurisdiction publishes similar guidance. In addition, they will already know which patients return and which do not. A provider that prepares early also avoids a rush in the first reporting cycle. The team knows who owns each indicator, and it knows which patients need a call.

Accountability Makes the Programme Real

Testing is easy to buy. Accountability is what makes the programme real. Groups that build for outcomes now will find reporting twice a year routine rather than disruptive.

Key Takeaways

Abu Dhabi measures change, not test volume. Providers report outcomes twice a year, and the indicators focus on fitness, metabolic markers, body composition, and later cognition. Consequently, a one-visit package cannot meet the standard. Hospital groups and resorts need retention, follow-up, and named physician ownership. Furthermore, individual targets replace one uniform threshold. Testing is easy to buy, but accountability makes the programme real.

Frequently Asked Questions

What is the Abu Dhabi JAWDA guidance for healthy longevity medicine?

It is guidance from the Abu Dhabi Department of Health. The department issued it in May, and it applies from the second half of 2026. It asks longevity providers to report patient outcomes twice a year.

It measures VO2max, HbA1c, blood pressure, LDL, and body composition by DEXA. Cognition joins from the first half of 2027. Targets are set per patient.

VO2max must improve by at least 5% at twelve months, or stay in the optimal range. The indicator only counts patients seen at least four times in twelve months.

It lists DNA methylation and whole body MRI as optional and needing further validation. It does not recommend telomere length outside research.

Build retention and follow-up into the offer, set individual targets, and name a physician who owns each abnormal result. The test menu becomes secondary.

Planning a longevity business?

TURN8 can review your readiness.

Scroll to Top